Trial Profile
A retrospective study to investigate the efficacy, safety and tolerability of Ceftaroline-fosamil in patients with beta-lactam allergy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Ceftaroline fosamil (Primary)
- Indications Community-acquired pneumonia; Methicillin-resistant Staphylococcus aureus infections; Skin and soft tissue infections
- Focus Adverse reactions; Therapeutic Use
- 21 Dec 2015 New trial record